Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Axogen, Inc. | CFO | Common Stock | 300K | $2.25M | $7.50 | Jan 1, 2024 | Direct |
BRAINSTORM CELL THERAPEUTICS INC. | Director | Common Stock | 12K | $21.3K | $1.77 | Jun 19, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AXGN | Axogen, Inc. | Jan 1, 2024 | 1 | $0 | 4 | Jan 4, 2024 | CFO |
AXGN | Axogen, Inc. | Dec 4, 2023 | 0 | $0 | 3 | Jan 4, 2024 | CFO |
BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Jun 19, 2023 | 1 | $0 | 4 | Jun 21, 2023 | Director |
BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Jun 19, 2023 | 0 | $0 | 3 | Jun 21, 2023 | Director |